3.3 Pulmonary Disease Progression
Key Takeaways
- In chronic hypercapnic COPD, a usual oxygen saturation target is about 88–92%; do not over-oxygenate as a reflex to drive the saturation to 100%.
- Interstitial lung disease, especially idiopathic pulmonary fibrosis, often declines faster than COPD, with high oxygen need and little reversible airway disease.
- A dyspnea crisis is panic and air hunger in a still-perfused patient; active dying looks like apnea, Cheyne–Stokes breathing, and mottling. Morphine or hydromorphone are first-line dyspnea drugs; detailed titration is taught later.
- Noninvasive ventilation can palliate COPD or ALS-overlap respiratory failure or become a mask burden that only prolongs dying; secretion burden needs positioning and planned suction limits, not endless airway assault.
Lung trajectories the CHPN exam actually writes
Pulmonary disease on Domain 1.C is not a pulmonary-function-test trivia contest. The 150-item HPCC CHPN exam wants you to recognize chronic obstructive pulmonary disease (COPD) as a long curve with crashes, interstitial lung disease (ILD) / idiopathic pulmonary fibrosis (IPF) as a faster slide, pulmonary hypertension as right-heart failure with infusion complexity, and lung cancer as an overlap that can add hemoptysis, obstruction, and the solid-tumor drop from Section 3.1. Dyspnea treatment with opioids is introduced here because it is how dying lungs are comforted; milligram-by-milligram titration belongs in a later symptom chapter.
COPD: FEV1, BODE, and the 88–92% oxygen rule
Forced expiratory volume in one second (FEV1) stages obstruction, but hospice eligibility is a function-and-crisis story, not a single percent predicted. A patient with FEV1 under 30% predicted is often in very severe obstruction, yet a higher FEV1 with cachexia, right-heart strain, and back-to-back exacerbations can be just as late. The BODE index (body-mass index, obstruction, dyspnea, exercise capacity) is a conceptual prognostic bundle: lower BMI, worse FEV1, worse dyspnea grade, and shorter six-minute walk all point to higher mortality. You are not asked to compute BODE by hand on every stem, but you should recognize that dyspnea and exercise capacity can outweigh a “not that low” FEV1.
CO2 retainers live with chronic hypercapnia. The operational CHPN rule is: in chronic hypercapnia, target oxygen saturation about 88–92%. Do not over-oxygenate as a reflex. Driving saturation to 100% with high-flow oxygen can worsen hypercapnia (V/Q mismatch and the Haldane effect—not the old “never give oxygen or they will stop breathing” myth). Treat hypoxemia; do not treat the pulse-oximeter’s desire for a perfect number.
COPD exacerbations are the hospitalizations that mark decline: more frequent, less complete recovery, more home oxygen, more noninvasive ventilation (NIV) in the emergency department. Between crashes, the patient may still sit in a chair. That recovered-looking interval is why families delay hospice. Name the stacked exacerbations as the trajectory.
ILD/IPF, pulmonary hypertension, and lung-cancer overlap
IPF and many fibrotic ILDs do not reverse with bronchodilators. The curve is often shorter than COPD: rising oxygen liters, dry cough, clubbing, and an acute exacerbation that is frequently a terminal event rather than a recoverable COPD flare. High-flow oxygen at home is common. Prognosis after an ILD exacerbation is poor enough that a hospice referral during that hospitalization is not “giving up too soon.”
Pulmonary hypertension presents with exertional syncope, edema, and right-heart failure. Prostacyclin infusions and other pulmonary vasodilators create the same coverage problem as cardiac inotropes: selected programs continue them for comfort, many hospices cannot. Coordinate; do not yank a drip without a plan for rebound pulmonary hypertensive crisis if the goal is still time at home.
Lung cancer overlaps COPD in smokers and can add post-obstructive pneumonia, hemoptysis, SVC syndrome, and the solid-tumor functional drop. Do not attribute every new dyspnea in a COPD patient to “just COPD” when there is weight loss, hemoptysis, or a new focal finding.
| Condition | Typical hospice curve | Oxygen / support trap |
|---|---|---|
| COPD | Years of decline with recoverable exacerbations, then incomplete recovery | Over-oxygenating CO2 retainers above about 88–92% saturation |
| IPF / fibrotic ILD | Faster slide; exacerbations often terminal | Assuming a bronchodilator burst will restore the COPD-like baseline |
| Pulmonary hypertension | Right-heart failure, syncope, edema | Stopping prostacyclin infusions without a crisis plan |
| Lung cancer plus COPD | Solid-tumor drop plus obstruction or bleeding | Treating only the COPD and missing the cancer emergency |
Dyspnea crisis versus dying, NIV as palliation versus burden, opioids, secretions
A dyspnea crisis is sudden air hunger in a patient who is still perfusing: tripoding, accessory muscles, diaphoresis, wide-eyed panic, speaking in few-word sentences, strong pulse. Treat the crisis: positioning, fan, calm presence, oxygen to the appropriate target, a possible NIV trial, and an opioid. Morphine or hydromorphone are first-line dyspnea drugs in hospice and palliative care. They reduce air-hunger perception. Comfort doses are not the same as a planned respiratory arrest. Titration math is a later chapter; the Domain 1.C point is that opioids belong in the pulmonary toolbox, not only in the pain toolbox.
Active dying looks different: Cheyne–Stokes or agonal breathing, long apneas, mottling, fading pulses, less awareness. NIV in that phase is often a tight mask on a dying face—claustrophobia, skin breakdown, delayed last words. A time-limited NIV trial is honest palliation: if work of breathing falls and the patient can speak or rest, continue; if the mask only prolongs gasping, stop. COPD hypercapnic failure is the classic benefit setting. IPF and dying respiratory failure more often find NIV burdensome.
Secretion burden in advanced lung disease is pooled mucus the patient can no longer cough. Deep repeated suctioning can worsen distress. Repositioning, brief shallow suction if a plug is audible and the patient wants it, and later-chapter antisecretory drugs are the comfort path. Teach families that noisy upper-airway secretions in active dying are more a listener problem than a drowning; that distinction keeps you from treating dying as an airway emergency.
A CO2-retaining COPD patient on home oxygen is recovering from a dyspnea crisis. Current saturation is 94% on 5 L/min. Which oxygen target is appropriate in chronic hypercapnia once the crisis is being treated?
Which statement about interstitial lung disease or idiopathic pulmonary fibrosis versus COPD is most accurate for CHPN planning?
A family asks whether a sudden gasping episode means death has started. The patient is tripoding, diaphoretic, and speaking in three-word sentences, with a strong radial pulse. Which interpretation is best?